Skip to content

Study · In vitro (cells) · 2003

1 result

Actions of GnRH antagonists on IGF-II, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells.

Weiss JM, Krautmacher B, Polack S, Diedrich K, Ortmann O

European journal of endocrinology1 Jul 2003Cited by 12 (Europe PMC)

PMID12824863 (opens in a new tab)DOI10.1530/eje.0.1490031 (opens in a new tab)PepBankPUB-12824863
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Mechanism

    In cultured human granulosa-lutein cells, triptorelin did not affect IGF-II, IGFBP-2 or PAPP-A.

    In plain wordsIn cells, triptorelin did not affect IGF-II, IGFBP-2 or PAPP-A.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    No significant changeIGF-II, IGFBP-2 and PAPP-A
    Study

    humann: not reported in source

    Cultured human granulosa-lutein cells
    Outcome group
    Growth hormone and IGF-1 · Reproductive and sexual health
    Studied dose
    1 nmol/l · 48 hAs given in this study (human).

    Source sentences

    Summary
    GnRHants and triptorelin did not affect IGF-II, IGFBP-2 or PAPP-A.
    2 context sentences
    Summary · context
    In vitro cell culture study in a research laboratory of a university hospital.
    Summary · context
    Cells were treated with triptorelin, cetrorelix or ganirelix, 1 nmol/l each, for 48 h.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 4Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Versions 2 to 3

    27 Oct 2026, 16:35 UTC

    The same notice was added 2 times, first on 27 Oct 2026, 16:35 UTC. The status did not change between them.

    Study data updated · source update from Europe PMC

  3. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.